Jobs / United States / Astrazeneca Pharmaceuticals Lp
Director Oncology Federal Accounts
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k. Most were filed at wage level II (47%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Join a highly valued, Oncology Care & Access Leadership team fundamental in realizing the potential of our life-changing medicines. Working with new drugs, new digital approaches, and ever-changing environments, it’s crucial that we remain flexible and on top of the detail. Running, thinking, and acting fast to make smart decisions and get the right medicines to patients at the right time. We lead the way for the industry with our pioneering valued-based agreements and Innovative Value Strategy solutions. It’s our determination and unwavering belief in the power of our medicines, and the science sitting behind them, that drives us to ensure their value is realized. Inspired by our people, patients, and pipeline, we work cross-functionally to leverage our shared skills, knowledge, and entrepreneurial spirit to change the way medicines are assessed and perceived and turn ambitions into reality. Director Oncology Federal Accounts (DOFA) Role As a Director Oncology Federal Accounts, you will have responsibility for Federal Accounts including VA Medical Centers and Military Treatment Facilities (DoD Accounts) where you’ll play a pivotal role leveraging your federal expertise, network and clinical & business knowledge to make meaningful impact on oncology patient care. In this role, you will serve as the subject matter expert across the Veteran Health Administration (VHA) and DoD Military Treatment Facilities (MTF) nationally to deliver AstraZeneca’s Oncology cutting-edge science and commercial capabilities to pharmacy and oncology key decision makers to enable pull through of Federal product access and advance AZ’s presence in the oncology and hematology market. The DOFA leads a team of Oncology Federal Account Managers that work with identified VAMC and MTF key stakeholders and decision makers including Pharmacy Chiefs, Oncology Pharmacy and overall Oncology HCPs (e.g., pharmacy, medical, quality) to advance AstraZeneca business priorities including but not limited to new product/indication introduction and launch, portfolio and product value proposition communication, formulary product access achievement, engage oncology pathway stakeholders, and contract pull-through. You will work with your external federal network and build deep and strong relationships with key stakeholders throughout the Federal Systems. The DOFA utilizes all available resources to facilitate engagements with Federal healthcare professionals to deliver product access and build relationships to achieve business objectives over a specific geography. You will develop and maintain in-depth knowledge of market, demographic, federal payers, and patient populations that impact the account. In addition, you will be expected to pull through on formulary approvals, economic opportunities and gaining an understanding of quality programs, initiatives, and treatment algorithms for the targeted patient populations. This individual will develop, lead and facilitate AstraZeneca cross-functional customer-facing team, Federal account planning to implement and pull through of VAMC site level strategies for oncology consistent with mutual business objectives; and closely collaborates with cross functional internal and external stakeholders to ensure effective plan implementation. The DOFA will also communicate insights and provide federal expertise to oncology brand teams for development of VA brand Strategy across Oncology Portfolio brands This role reports to the VP, OC&A Key Responsibilities: Federal Expertise & Stakeholder Engagement • Develop and maintain business to business relationships with VA Medical Center (VAMC) and DoD MTF leadership and oncology decision makers and other stakeholders as appropriate. • Develops and maintains in-depth